Practical considerations for the pharmacokinetic and immunogenic assessment of antibody-drug conjugates.
about
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthLC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.Antibody-drug conjugates nonclinical support: from early to late nonclinical bioanalysis using ligand-binding assays.Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays.Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects.
P2860
Q36316911-1430DB15-7CDF-48EB-8422-3C140FDD5280Q38571078-57A74CC4-C7EA-4FE6-83B1-3D23911AAD1EQ38777938-192A7DD2-46A7-4D6C-99BF-58EA5B006D58Q40677785-3522ADB1-D9D0-462C-B9BA-A0711BC31DD9Q46535634-95185D11-DD58-4573-895E-0C60CD73C982Q47568807-8492AD9F-293D-4E12-B48E-30B9E75C5458Q48222378-A04E1642-FEE6-4B14-9113-796EFF7E47D2
P2860
Practical considerations for the pharmacokinetic and immunogenic assessment of antibody-drug conjugates.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Practical considerations for t ...... t of antibody-drug conjugates.
@en
type
label
Practical considerations for t ...... t of antibody-drug conjugates.
@en
prefLabel
Practical considerations for t ...... t of antibody-drug conjugates.
@en
P2860
P1433
P1476
Practical considerations for t ...... t of antibody-drug conjugates.
@en
P2093
Melody Sauerborn
William van Dongen
P2860
P2888
P304
P356
10.1007/S40259-014-0096-Z
P577
2014-08-01T00:00:00Z